false
0001779372
0001779372
2026-06-30
2026-06-30
0001779372
us-gaap:CommonStockMember
2026-06-30
2026-06-30
0001779372
us-gaap:WarrantMember
2026-06-30
2026-06-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section
13 or 15(d) of the Securities and Exchange Act of 1934
Date of Report (Date
of earliest event reported): June 30, 2026
HEARTBEAM, INC.
(Exact name of Registrant
as specified in its charter)
| Delaware |
|
001-41060 |
|
47-4881450 |
|
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
2118 Walsh Avenue,
Suite 210
Santa Clara, CA
95050
(Address of principal
executive offices, including zip code)
(408) 899-4443
(Registrant’s
telephone number, including area code)
Check the appropriate
box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following
provisions:
| ☐ |
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). |
Securities registered
pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock |
|
BEAT |
|
NASDAQ |
| Warrant |
|
BEATW |
|
NASDAQ |
Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule
12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
☒
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 3.01. Notice of Delisting or Failure to
Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On June 30, 2026, HeartBeam, Inc. (the “Company”)
received a deficiency letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)
notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share (the “Common
Stock”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain
a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2)
(the “Minimum Bid Price Requirement”).
The Notice has no immediate effect on the continued
listing status of the Common Stock on The Nasdaq Capital Market, and, therefore, the Company’s listing remains fully effective.
In accordance with Nasdaq Listing Rule 5810(c)(3)(A),
the Company is provided a compliance period of 180 calendar days from the date of the Notice, or until December 28, 2026, to regain compliance
with the Minimum Bid Price Requirement. To regain compliance, the closing bid price of the Common Stock must meet or exceed $1.00 per
share for a minimum of ten consecutive business days prior to December 28, 2026.
If the Company is not in compliance with the Minimum
Bid Price Requirement by December 28, 2026, the Company may be afforded a second 180 calendar day compliance period. To qualify for this
additional compliance period, the Company will be required to meet the continued listing requirement for market value of publicly held
shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price requirement.
The Company intends to actively monitor the closing
bid price of the Common Stock and will evaluate available options to regain compliance with the Minimum Bid Price Requirement. However,
there can be no assurance that the Company will regain compliance with the Minimum Bid Price Requirement during the 180-day compliance
period, secure a second period of 180 days to regain compliance, or maintain compliance with the other Nasdaq listing requirements. If
the Company does not regain compliance within the allotted compliance period, including any extensions that Nasdaq grants, Nasdaq will
provide notice that the Common Stock will be subject to delisting. The Company would then be entitled to appeal that determination to
a Nasdaq hearings panel.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
| |
HeartBeam, Inc. |
| |
|
|
| Date: July 2, 2026 |
By: |
/s/ Timothy Cruickshank |
| |
Name: |
Timothy Cruickshank |
| |
Title: |
Chief Financial Officer |